SCHEMBL4595327

SCHEMBL4595327

Fc1cccc(C=NOCl)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.62
RAB9A P51151 5/20 0.62
PKM P14618 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2D6 P10635 1/20 0.62
MAPK1 P28482 1/20 0.62
THPO P40225 1/20 0.62
CHRM5 P08912 1/20 0.62
GRM5 P41594 1/20 0.62
BLM P54132 1/20 0.62
PMP22 Q01453 1/20 0.62
NFE2L2 Q16236 9/20 0.52
MAOB P27338 1/20 0.47
PTGS1 P23219 2/20 0.46
PTGS2 P35354 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6076987 0.81 NPC1 (0.62) NPC1RAB9APKMCYP1A2CYP3A4
SCHEMBL6076991 0.81 NPC1 (0.62) NPC1RAB9APKMCYP1A2CYP3A4
SCHEMBL28612858 0.79 CYP1A2 (0.34) NPC1RAB9APKMCYP1A2CYP3A4
SCHEMBL28605730 0.78 CHRM5 (0.64) NPC1RAB9ACYP1A2CYP2D6CHRM5
SCHEMBL28618284 0.78 ALDH1A1 (0.50) PKMCYP1A2CYP2D6CHRM5PTGS1
SCHEMBL12017614 0.77 NPC1 (1.00) NPC1RAB9APKMCYP1A2CYP3A4
SCHEMBL29392337 0.77 NPC1 (1.00) NPC1RAB9APKMCYP1A2CYP3A4
SCHEMBL12497017 0.77 NPC1 (1.00) NPC1RAB9APKMCYP1A2CYP3A4
SCHEMBL11099642 0.77 RECQL (0.51) NPC1RAB9APKMNFE2L2MAOB
SCHEMBL11099640 0.77 RECQL (0.51) NPC1RAB9APKMNFE2L2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937674-A1 ISOXAZOLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-07-02 EP disclosed
US-7378435-B2 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US disclosed
WO-2007042420-A1 ISOXAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-04-19 WO disclosed
US-20070082936-A1 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082936-A1 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives GABRA5, GABRA4, CHRNA5 NPC1 1358/4885RAB9A 1381/4885PKM 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.